title: The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process.
authors.affiliation: Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. dan.roden@vanderbilt.edu
authors.forename: Dan M
authors.initials: DM
authors.lastname: Roden
authors.forename: Robert
authors.initials: R
authors.lastname: Temple
mesh_terms: D002317:Cardiovascular Agents / Q000009:adverse effects / Q000592:standards*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D002317:Cardiovascular Agents